Company

Differentiated alphavirus infection diagnostics: an outlook for epidemiology and patient care

For some time now, alphaviruses, including well-known viruses like chikungunya virus, have not only been a problem in tropical regions. Due to climate change and the associated spread of mosquitoes as vectors the number of documented infections is also on the rise in Europe. Precise diagnostics and epidemiological monitoring are becoming more and more important […]

Science

High concordance of serological methods for EBV staging

A new collaborative study by Euroimmun and researchers in Türkiye reports that both ELISA and immunoblot show excellent agreement with the reference standard — indirect immunofluorescence assay (IFA) — for serological staging of Epstein-Barr virus (EBV) infections. A widespread infection EBV is a ubiquitous herpesvirus that infects more than 95% of the global population, usually

Products

Serological diagnostics of Oropouche virus infections: Euroimmun Brazil launches new ANVISA-approved ELISAs

Climate change, population growth, global travel and shifting lifestyles all increase both how likely and how quickly infectious diseases spread. This is especially true for arboviruses, which are vector-borne and include dengue virus, chikungunya virus and Oropouche virus. Oropouche fever in Brazil Brazil is a powerful example: Since the end of 2023, the incidence of

Science

Robust performance of serological tests for coeliac disease in Tunisia

Serological tests for coeliac disease-specific antibodies showed exceptionally high sensitivity and specificity in a Tunisian cohort, underscoring their diagnostic utility. The recently published findings stem from a collaborative study between Euroimmun and various laboratories in Tunisia. Studying a unique population Coeliac disease is an autoimmune disorder triggered in genetically predisposed individuals by gluten ingestion. It

UNIQO 160 #UNIQOmeetsNeuro
Products

Euroimmun sets new standards in serological neurological diagnostics

Long anticipated – now available: the neurology portfolio for the UNIQO 160, our all-in-one automated IFA system, has been expanded by nine more indirect immunofluorescence assays (IFA). While the previous portfolio primarily contained classic Euroimmun BIOCHIP Mosaics with different tissue sections as substrates, these new additions are highly relevant monospecific IFA with a particular focus

Scroll to Top